Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Acta Ophthalmol
1 Am Heart J
1 Am J Cardiol
1 Am J Clin Nutr
1 Am J Kidney Dis
3 Am J Manag Care
2 Am J Ophthalmol
1 Ann Intern Med
5 Biochem Biophys Res Commun
2 Circ Heart Fail
2 Diabet Med
1 Diabetes
11 Diabetes Care
1 Diabetes Obes Metab
3 Diabetologia
1 Hypertension
2 Invest Ophthalmol Vis Sci
1 J Am Coll Cardiol
1 J Am Soc Nephrol
1 J Biol Chem
5 J Clin Endocrinol Metab
3 J Diabetes Complications
1 Metabolism
6 N Engl J Med
1 Ophthalmology
1 Pediatr Diabetes
10 PLoS One
1 Retina

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Ophthalmol

  1. KUBIN AM, Wirkkala J, Keskitalo A, Ohtonen P, et al
    Handheld fundus camera performance, image quality and outcomes of diabetic retinopathy grading in a pilot screening study.
    Acta Ophthalmol. 2021 Mar 16. doi: 10.1111/aos.14850.
    PubMed         Abstract available

    Am Heart J

  2. FABRIS E, Ten Berg JM, Hermanides RS, Ottervanger JP, et al
    NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial.
    Am Heart J. 2021;233:78-85.
    PubMed         Abstract available

    Am J Cardiol

  3. BANSAL A, Gupta S, Aggarwal M, Jain V, et al
    Impact of Malnutrition on Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2020 Dec 8. pii: S0002-9149(20)31336.

    Am J Clin Nutr

    "Instead of what," and repeated 4-year interval change regarding red meat and T2D: increasing causal inference in nutritional epidemiology through methodological advances.
    Am J Clin Nutr. 2021 Jan 29. pii: 6123964. doi: 10.1093.

    Am J Kidney Dis

  5. PYNE L, Walsh M
    Allopurinol: Good for Gout But Not for Preventing Loss of Kidney Function.
    Am J Kidney Dis. 2021;77:459-461.

    Am J Manag Care

  6. AHERN DK, Aberger EW, Wroblewski JP, Zheng Q, et al
    Behavior-based diabetes management: impact on care, hospitalizations, and costs.
    Am J Manag Care. 2021;27:96-102.
    PubMed         Abstract available

  7. LISS DT, Kang RH, Lancki N, O'Brien MJ, et al
    Costs for commercially insured adults prescribed second-line diabetes medications.
    Am J Manag Care. 2021;27:e72-e79.
    PubMed         Abstract available

  8. LANDON BE, Zaslavsky AM, Souza J, Ayanian JZ, et al
    Use of diabetes medications in traditional Medicare and Medicare Advantage.
    Am J Manag Care. 2021;27:e80-e88.
    PubMed         Abstract available

    Am J Ophthalmol

  9. HUTTON DW, Glassman AR, Stein JD, Bressler NM, et al
    Costs of Managing Diabetic Macular Edema with Good Visual Acuity with Aflibercept, Laser or Observation: DRCR Retina Network Protocol V.
    Am J Ophthalmol. 2021 Mar 10. pii: S0002-9394(21)00103.
    PubMed         Abstract available

  10. ABRAHAM JR, Wykoff CC, Arepalli S, Lunasco L, et al
    Aqueous Cytokine Expression and Higher Order OCT Biomarkers: Assessment of the Anatomic-Biologic Bridge in the IMAGINE DME Study.
    Am J Ophthalmol. 2021;222:328-339.
    PubMed         Abstract available

    Ann Intern Med

  11. GRIFFIN TP, Dinneen SF
    In T2DM, weekly insulin icodec did not differ from daily glargine for reducing HbA1c or significant/severe hypoglycemia.
    Ann Intern Med. 2021;174:JC34.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  12. GADDAM RR, Kim YR, Li Q, Jacobs JS, et al
    Genetic deletion of miR-204 improves glycemic control despite obesity in db/db mice.
    Biochem Biophys Res Commun. 2020;532:167-172.
    PubMed         Abstract available

  13. MOTEGI M, Himeno T, Nakai-Shimoda H, Inoue R, et al
    Deficiency of glucagon gene-derived peptides induces peripheral polyneuropathy in mice.
    Biochem Biophys Res Commun. 2020;532:47-53.
    PubMed         Abstract available

  14. ZHANG X, Li D, Zhu X, Wang Y, et al
    Structural characterization and cryo-electron tomography analysis of human islet amyloid polypeptide suggest a synchronous process of the hIAPP1-37 amyloid fibrillation.
    Biochem Biophys Res Commun. 2020;533:125-131.
    PubMed         Abstract available

  15. ZHANG M, Zhao S, Xu C, Shen Y, et al
    Ablation of lncRNA MIAT mitigates high glucose-stimulated inflammation and apoptosis of podocyte via miR-130a-3p/TLR4 signaling axis.
    Biochem Biophys Res Commun. 2020;533:429-436.
    PubMed         Abstract available

  16. OUYANG YN, Jin YX, Zhao XR, Chen M, et al
    Revealing metabolic pathways relevant to prediabetes based on metabolomics profiling analysis.
    Biochem Biophys Res Commun. 2020;533:188-194.
    PubMed         Abstract available

    Circ Heart Fail

  17. YEOH SE, Dewan P, Jhund PS, Inzucchi SE, et al
    Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy?
    Circ Heart Fail. 2020 Nov 9. doi: 10.1161/CIRCHEARTFAILURE.120.007879.
    PubMed         Abstract available

  18. EZZEDDINE FM, Mulpuru SK, Borlaug BA
    A Tough Time Running Around the Block.
    Circ Heart Fail. 2020;13:e007182.

    Diabet Med

  19. SINCLAIR A, Bellary S, Dhatariya KK
    Diabetes in Older Adults - time to include frailty as a care indicator.
    Diabet Med. 2021 Mar 16:e14560. doi: 10.1111/dme.14560.
    PubMed         Abstract available

  20. HADAD R, Larsen BS, Weber P, Stavnem D, et al
    Night-time Heart rate variability identifies High-risk patients among people with uncomplicated type 2 diabetes mellitus.
    Diabet Med. 2021 Mar 13:e14559. doi: 10.1111/dme.14559.
    PubMed         Abstract available


  21. BAGGER JI, Grondahl M, Lund A, Holst JJ, et al
    Glucagonostatic Potency of GLP-1 in Patients with Type 2 Diabetes, in Patients with Type 1 Diabetes and in Healthy Controls.
    Diabetes. 2021 Mar 15. pii: db20-0998. doi: 10.2337/db20-0998.
    PubMed         Abstract available

    Diabetes Care

  22. SPINETTI G, Sangalli E, Tagliabue E, Maselli D, et al
    MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34(+) Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia.
    Diabetes Care. 2020;43:1520-1529.
    PubMed         Abstract available

  23. CHU PY, Hackstadt AJ, Chipman J, Griffin MR, et al
    Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas.
    Diabetes Care. 2020;43:1462-1470.
    PubMed         Abstract available

  24. NUYUJUKIAN DS, Koska J, Bahn G, Reaven PD, et al
    Blood Pressure Variability and Risk of Heart Failure in ACCORD and the VADT.
    Diabetes Care. 2020;43:1471-1478.
    PubMed         Abstract available

  25. SHAO H, Shi L, Fonseca VA
    Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials With Sodium-Glucose Transporter 2 Inhibitors.
    Diabetes Care. 2020;43:1530-1536.
    PubMed         Abstract available

  26. BUSE JB, Bain SC, Mann JFE, Nauck MA, et al
    Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial.
    Diabetes Care. 2020;43:1546-1552.
    PubMed         Abstract available

  27. MARX N, Grant PJ
    Prescribing Paradigm Shift? Damned If You Do, Damned If You Don't.
    Diabetes Care. 2020;43:1991-1993.

  28. BATTELINO T, Bergenstal RM
    Continuous Glucose Monitoring-Derived Data Report-Simply a Better Management Tool.
    Diabetes Care. 2020;43:2327-2329.

  29. HERMAN WH, Ratner RE
    Metformin Should Be Used to Treat Prediabetes in Selected Individuals.
    Diabetes Care. 2020;43:1988-1990.

  30. CHATURVEDI N, Eastwood S
    Prescribing by Ethnicity: (Im)precision Medicine?
    Diabetes Care. 2020;43:1687-1689.

  31. SCHWARTZ GG, Szarek M, Bittner VA, Bhatt DL, et al
    Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.
    Diabetes Care. 2021 Mar 15. pii: dc20-2842. doi: 10.2337/dc20-2842.
    PubMed         Abstract available

  32. JEYAM A, Colhoun H, McGurnaghan S, Blackbourn L, et al
    Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398.
    Diabetes Care. 2021 Mar 17. pii: dc21-er04b. doi: 10.2337.

    Diabetes Obes Metab

  33. HELLGREN M, Svensson AM, Franzen S, Ericsson A, et al
    The Burden Of Poor Glycemic Control In People With Newly Diagnosed Type 2 Diabetes In Sweden: A Health Economic Modeling Analysis Based On Nationwide Data.
    Diabetes Obes Metab. 2021 Mar 17. doi: 10.1111/dom.14376.
    PubMed         Abstract available


  34. SEGAR MW, Patel KV, Vaduganathan M, Caughey MC, et al
    Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.
    Diabetologia. 2021 Mar 13. pii: 10.1007/s00125-021-05426.
    PubMed         Abstract available

  35. BATISTA TM, Haider N, Kahn CR
    Defining the underlying defect in insulin action in type 2 diabetes.
    Diabetologia. 2021 Mar 17. pii: 10.1007/s00125-021-05415.
    PubMed         Abstract available

    Consequences of recurrent hypoglycaemia on brain function in diabetes.
    Diabetologia. 2021 Mar 18. pii: 10.1007/s00125-020-05369.
    PubMed         Abstract available


  37. OGUNLADE BO, Lazartigues E, Filipeanu CM
    Angiotensin Type 1 Receptor-Dependent Internalization of SARS-CoV-2 by Angiotensin-Converting Enzyme 2.
    Hypertension. 2021;77:e42-e43.

    Invest Ophthalmol Vis Sci

  38. LEE MW, Lee WH, Ryu CK, Lee YM, et al
    Peripapillary Retinal Nerve Fiber Layer and Microvasculature in Prolonged Type 2 Diabetes Patients Without Clinical Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2021;62:9.
    PubMed         Abstract available

  39. BISWAS S, Feng B, Chen S, Liu J, et al
    The Long Non-Coding RNA HOTAIR Is a Critical Epigenetic Mediator of Angiogenesis in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2021;62:20.
    PubMed         Abstract available

    J Am Coll Cardiol

  40. AGGARWAL R, Chiu N, Loccoh EC, Kazi DS, et al
    Rural-Urban Disparities: Diabetes, Hypertension, Heart Disease, and Stroke Mortality Among Black and White Adults, 1999-2018.
    J Am Coll Cardiol. 2021;77:1480-1481.

    J Am Soc Nephrol

  41. PETRILLO F, Iervolino A, Angrisano T, Jelen S, et al
    Dysregulation of Principal Cell miRNAs Facilitates Epigenetic Regulation of AQP2 and Results in Nephrogenic Diabetes Insipidus.
    J Am Soc Nephrol. 2021 Mar 16. pii: ASN.2020010031. doi: 10.1681/ASN.2020010031.
    PubMed         Abstract available

    J Biol Chem

  42. COCHRANE VA, Wu Y, Yang Z, ElSheikh A, et al
    Leptin modulates pancreatic beta-cell membrane potential through Src kinase-mediated phosphorylation of NMDA receptors.
    J Biol Chem. 2020;295:17281-17297.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  43. BROOS B, Charleer S, Bolsens N, Moyson C, et al
    Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting with Continuous Glucose Monitoring: FUTURE-PEAK.
    J Clin Endocrinol Metab. 2021 Mar 19. pii: 6178949. doi: 10.1210.
    PubMed         Abstract available

  44. WANDER PL, Boyko EJ
    Long-term fasting glycemic variability and microvascular complications in type 2 diabetes.
    J Clin Endocrinol Metab. 2021 Mar 15. pii: 6171137. doi: 10.1210.

  45. LI PF, Chen WL
    Response Letter to the Editor from Bello-Chavolla OY: "Are the Different Diabetes Subgroups Correlated With All-Cause, Cancer related, and Cardiovascular-related Mortality?"
    J Clin Endocrinol Metab. 2021 Mar 17. pii: 6174426. doi: 10.1210.

  46. BELLO-CHAVOLLA OY, Antonio-Villa NE, Fernandez-Chirino L, Vargas-Vazquez A, et al
    Letter to the Editor from Omar Yaxmehen Bello-Chavolla: "Are the Different Diabetes Subgroups Correlated With All-Cause, Cancer related, and Cardiovascular-related Mortality?"
    J Clin Endocrinol Metab. 2021 Mar 17. pii: 6174421. doi: 10.1210.

  47. COLLELUORI G, Aguirre L, Napoli N, Qualls C, et al
    Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2021 Mar 18. pii: 6178348. doi: 10.1210.
    PubMed         Abstract available

    J Diabetes Complications

  48. MELENA I, Bjornstad P, Schafer M, Hunter KS, et al
    Serum copeptin and NT-proBNP is associated with central aortic stiffness and flow hemodynamics in adolescents with type 1 diabetes: A pilot study.
    J Diabetes Complications. 2021 Feb 6:107883. doi: 10.1016/j.jdiacomp.2021.107883
    PubMed         Abstract available

  49. XU N, Zhao S, Jia W, Wang L, et al
    WITHDRAWN: Endothelial progenitor cells deliver exogenous miR-126 via exosomes to accelerate wound healing in diabetes mellitus.
    J Diabetes Complications. 2020 Dec 31:107844.
    PubMed         Abstract available

  50. STOILOV SI, Fountoulakis N, Panagiotou A, Thomas S, et al
    Non-linear renal function decline is frequent in patients with type 2 diabetes who progress fast to end-stage renal disease and is associated with African-Caribbean ethnicity and HbA1c variability.
    J Diabetes Complications. 2021 Jan 28:107875.
    PubMed         Abstract available


  51. CIARDULLO S, Perseghin G
    Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.
    Metabolism. 2021 Mar 11:154752. doi: 10.1016/j.metabol.2021.154752.
    PubMed         Abstract available

    N Engl J Med

  52. YOUNG MJ, Fuller PJ
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.

  53. BAKRIS GL, Agarwal R, Filippatos G
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2021;384:e42.

  54. MOURA-NETO JA, Ronco C
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.

    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.

  56. MAKEMBI AB, Mohamadou I, Galichon P
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.

  57. EDWARDS NC, Ferro CJ, Townend JN
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.


  58. MALHOTRA NA, Greenlee TE, Iyer AI, Conti TF, et al
    Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti-VEGF Therapy for Diabetic Macular Edema in the United States.
    Ophthalmology. 2021 Mar 11. pii: S0161-6420(21)00196.
    PubMed         Abstract available

    Pediatr Diabetes

  59. VLAHOU CH, Petrovski G, Korayem M, Al Khalaf F, et al
    Outpatient clinic-wide psychological screening for children and adolescents with type 1 diabetes in Qatar: An initiative for integrative healthcare in the Gulf region.
    Pediatr Diabetes. 2021 Mar 14. doi: 10.1111/pedi.13200.
    PubMed         Abstract available

    PLoS One

  60. TONG WT, Lee YK, Ng CJ, Lee PY, et al
    Factors influencing implementation of an insulin patient decision aid at public health clinics in Malaysia: A qualitative study.
    PLoS One. 2020;15:e0244645.
    PubMed         Abstract available

  61. NARAVANE AV, Mundae R, Zhou Y, Santilli C, et al
    Short term visual and structural outcomes of anti-vascular endothelial growth factor (anti-VEGF) treatment delay during the first COVID-19 wave: A pilot study.
    PLoS One. 2021;16:e0247161.
    PubMed         Abstract available

  62. AMADU I, Ahinkorah BO, Afitiri AR, Seidu AA, et al
    Assessing sub-regional-specific strengths of healthcare systems associated with COVID-19 prevalence, deaths and recoveries in Africa.
    PLoS One. 2021;16:e0247274.
    PubMed         Abstract available

  63. ARMSTRONG K, Soltoff A, Rieu-Werden M, Metlay J, et al
    Use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers associated with lower risk of COVID-19 in household contacts.
    PLoS One. 2021;16:e0247548.
    PubMed         Abstract available

  64. ITO H, Matsumoto S, Izutsu T, Kusano E, et al
    Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation.
    PLoS One. 2021;16:e0248577.
    PubMed         Abstract available

  65. IBRAHIM N, Treluyer JM, Briand N, Godot C, et al
    Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial.
    PLoS One. 2021;16:e0248549.
    PubMed         Abstract available

  66. JAWORSKI M, Panczyk M, Sliwczynski A, Brzozowska M, et al
    Schizophrenic patients with type 2 diabetes: An 8-year population-based observational study.
    PLoS One. 2021;16:e0248407.
    PubMed         Abstract available

  67. EGEDE LE, Walker RJ, Dismuke-Greer CE, Pyzyk S, et al
    Cost-effectiveness of financial incentives to improve glycemic control in adults with diabetes: A pilot randomized controlled trial.
    PLoS One. 2021;16:e0248762.
    PubMed         Abstract available

  68. BACKESTROM A, Papadopoulos K, Eriksson S, Olsson T, et al
    Acute hyperglycaemia leads to altered frontal lobe brain activity and reduced working memory in type 2 diabetes.
    PLoS One. 2021;16:e0247753.
    PubMed         Abstract available

  69. HEISE M, Fink A, Baumert J, Heidemann C, et al
    Patterns and associated factors of diabetes self-management: Results of a latent class analysis in a German population-based study.
    PLoS One. 2021;16:e0248992.
    PubMed         Abstract available


  70. LENT-SCHOCHET D, Lo T, Luu KY, Tran S, et al
    Natural History and Predictors of Vision Loss in Eyes with Diabetic Macular Edema and Good Initial Visual Acuity.
    Retina. 2021 Mar 9. pii: 00006982-900000000-95537.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.